IT Security Intern
Danaher Corporation
Summary
The IT Security Intern is responsible for assisting with the implementation of enhanced security controls to protect IDT's global IT environment. This position reports to the IT Security Manager and is part of the IT Security Team located in Coralville, IA and will be an on-site role.
Job description
In this role, you will have the opportunity to:
- Collaborate with various global IT teams.
- Assist with the implementation of data loss prevention controls.
- Assist with the implementation of endpoint privilege management controls.
- Participate in threat and vulnerability processes, identifying and collaborating with IT stakeholders.
Requirements
- Currently pursuing a degree in cybersecurity or similar Information Technology related discipline.
- Working knowledge of IT and Cybersecurity principles.
- Strong verbal and written communication skills.
- Ability to work independently and in a team environment
- Prior hands-on working experience in an IT related field.
Benefits
- Paid time off
- Medical insurance
- Dental insurance
- Vision insurance
- 401(k)
- Bonus/incentive pay
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.